ATMI has acquired LevTech, a provider of disposable mixing technologies to the biotechnology and pharmaceutical industries, in a $27 million cash transaction.
Subscribe to our email newsletter
Based in Lexington, Kentucky, LevTech will be combined with ATMI’s existing LifeSciences business focused on single-use bioprocess containers and processes for the biopharmaceutical industry.
Doug Neugold, CEO of ATMI, said: “The addition of LevTech’s innovative products, intellectual property, and market share puts ATMI’s LifeSciences business in a preeminent position for single-use manufacturing applications in the biopharmaceutical market.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.